Azafaros develops therapies in the field of rare metabolic disorders.
Location: Netherlands, North Holland, Bussum
Employees: 11-50
Total raised: $28M
Founded date: 2018
Investors 2
| Date | Name | Website |
| - | BioGenerat... | biogenerat... |
| - | Forbion | forbion.co... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 18.02.2020 | Series A | $28M | - |
Mentions in press and media 5
| Date | Title | Description | Source |
| 12.03.2024 | Azafaros announces completion of 12-week Phase 2 RAINBOW stu... | - | globenewsw... |
| 23.01.2024 | Azafaros to present data from PRONTO study in patients with ... | • Four posters with baseline data from the natural history (PRONTO) study in patients with GM1 and G... | forbion.co... |
| 18.02.2020 | Daily funding roundup - February 18th, 2020 | Arize AI raised $4M; InVideo secured $2.5M; Sharpist landed $5M; Copper.co closed $8M Arize AI: Ariz... | vator.tv/n... |
| 18.02.2020 | Azafaros Closes €25M Series A Financing | Azafaros B.V., a Leiden, The Netherlands-based rare metabolic disorders pipeline developer, closed a... | finsmes.co... |
| 06.02.2020 | European rare disease biotech Azafaros grabs $28M early fund... | Azafaros has grabbed €25 million ($27.5 million) in a series A investment boost as it looks to push ... | fiercebiot... |